Concentric Capital Strategies LP Has $352,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Concentric Capital Strategies LP cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 81.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 695 shares of the healthcare conglomerate's stock after selling 3,148 shares during the quarter. Concentric Capital Strategies LP's holdings in UnitedHealth Group were worth $352,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. CoreCap Advisors LLC boosted its stake in shares of UnitedHealth Group by 127.5% during the 4th quarter. CoreCap Advisors LLC now owns 3,553 shares of the healthcare conglomerate's stock worth $1,797,000 after acquiring an additional 1,991 shares in the last quarter. Capital Advantage Inc. purchased a new position in shares of UnitedHealth Group in the fourth quarter valued at $237,000. Bridgeway Capital Management LLC boosted its position in shares of UnitedHealth Group by 10.5% in the 4th quarter. Bridgeway Capital Management LLC now owns 38,613 shares of the healthcare conglomerate's stock worth $19,533,000 after buying an additional 3,665 shares in the last quarter. Bowie Capital Management LLC raised its position in UnitedHealth Group by 22.1% during the fourth quarter. Bowie Capital Management LLC now owns 210,165 shares of the healthcare conglomerate's stock worth $106,314,000 after acquiring an additional 38,107 shares during the last quarter. Finally, Brevan Howard Capital Management LP grew its position in shares of UnitedHealth Group by 182.7% in the fourth quarter. Brevan Howard Capital Management LP now owns 22,109 shares of the healthcare conglomerate's stock valued at $11,184,000 after purchasing an additional 14,287 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Stock Performance

UNH stock traded down $4.83 during mid-day trading on Friday, reaching $380.72. The company had a trading volume of 8,371,190 shares, compared to its average volume of 4,716,091. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a one year low of $378.54 and a one year high of $630.73. The stock's 50-day simple moving average is $488.01 and its two-hundred day simple moving average is $522.60. The stock has a market capitalization of $346.54 billion, a P/E ratio of 24.56, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 2.21%. UnitedHealth Group's payout ratio is 35.18%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on UNH shares. KeyCorp reduced their target price on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Mizuho lifted their price target on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Raymond James reiterated a "strong-buy" rating and set a $540.00 target price (down from $635.00) on shares of UnitedHealth Group in a research report on Monday, April 21st. Finally, Robert W. Baird dropped their price target on shares of UnitedHealth Group from $640.00 to $510.00 and set an "outperform" rating for the company in a research report on Tuesday, April 29th. Four analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.